THE ASSOCIATION BETWEEN PROGNOSIS AND SARCOPENIA ASSESSED BY PSOAS MUSCLE MEASUREMENTS IN ELDERLY MALE PATIENTS WITH COVID-19

dc.contributor.authorPolat, Musa
dc.contributor.authorSalbas, Cigdem Samur
dc.contributor.authorSari, Sema
dc.contributor.authorDogan, Mustafa
dc.contributor.authorCam, Selim
dc.contributor.authorKaradag, Ahmet
dc.date.accessioned2024-11-07T13:31:42Z
dc.date.available2024-11-07T13:31:42Z
dc.date.issued2021
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractIntroduction: Sarcopenia, which is defined as a generalized loss of skeletal muscle mass and function, is an important clinical condition, especially among elderly patients with comorbidities. This study assesses the association between prognosis and sarcopenia assessed by psoas muscle measurements in elderly male patients with coronavirus disease 2019. Materials and Methods: This study included 130 consecutive elderly male patients hospitalized with coronavirus disease 2019. The participants were followed until their time of discharge or death. The psoas muscle crosssectional area, psoas density, and psoas muscle index measurements were performed based on a single-axial computed tomography section at the L2 vertebral corpus. The outcome measurements of the patients were determined as intensive care unit admission and mortality. Results: During the clinical course of these patients, 29.2% (38) were transferred to the intensive care unit, and 13.1% (17) died. The interclass correlation coefficients for the psoas muscle cross-sectional area and density were 0.91 and 0.93, respectively, between observers. Low psoas muscle index is significantly associated with mortality (p = 0.001), and the probability of mortality increases approximately 5-30 times as the psoas muscle index decreases. No factors were identified as being significantly associated with intensive care unit admission. Conclusion: In elderly male patients who are hospitalized due to coronavirus disease 2019, an assessment of the psoas muscle may provide additional information on the prognosis of the disease.
dc.identifier.doi10.31086/tjgeri.2021.2532021
dc.identifier.endpage566
dc.identifier.issn1304-2947
dc.identifier.issn1307-9948
dc.identifier.issue4
dc.identifier.startpage557
dc.identifier.trdizinid505438
dc.identifier.urihttps://doi.org/10.31086/tjgeri.2021.2532021
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/505438
dc.identifier.urihttps://hdl.handle.net/11480/14984
dc.identifier.volume24
dc.identifier.wosWOS:000737328600013
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGunes Kitabevi Ltd Sti
dc.relation.ispartofTurkish Journal of Geriatrics-Turk Geriatri Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241106
dc.subjectSarcopenia
dc.subjectCOVID-19
dc.subjectIntensive Care Units
dc.subjectMortality
dc.titleTHE ASSOCIATION BETWEEN PROGNOSIS AND SARCOPENIA ASSESSED BY PSOAS MUSCLE MEASUREMENTS IN ELDERLY MALE PATIENTS WITH COVID-19
dc.typeArticle

Dosyalar